Skip to main content

Gout: ULT Therapy (Recommended for eMeasure Trial Approval)

CBE ID
2550e
Endorsement Status
Approval for Trial Use Removed
1.1 New or Maintenance
Maintenance
Previous Endorsement Cycle
Spring 2019
Is Under Review
No
1.3 Measure Description

Percentage of patients aged 18 and older with a diagnosis of gout and either tophus/tophi or at least two gout flares (attacks) in the past year who have a serum urate level > 6.0 mg/dL, who are prescribed urate lowering therapy (ULT)

    • 1.14 Numerator

      Patients who are prescribed urate lowering therapy (ULT)

    • 1.15 Denominator

      Adult patients aged 18 and older with a diagnosis of gout and a serum urate level > 6.8 mg/dL who have at least one of the following: presence of tophus/tophi or two or more gout flares (attacks) in the past year

    • Exclusions

      None

    • 1.13a Data dictionary not attached
      No
    • Most Recent Endorsement Activity
      Approval for Trial Use Removed Primary Care and Chronic Illness Spring Cycle 2019
      Initial Endorsement
      Last Updated
      Removal Date
    • Steward
      American College of Rheumatology
      Steward Organization POC Email
      [email protected]
      Steward Organization Copyright

      N/A - measure is still being tested

    • Risk Adjustment
      No risk adjustment or risk stratification
      Risk adjustment approach
      Off
      Risk adjustment approach
      Off
      Conceptual model for risk adjustment
      Off
      Conceptual model for risk adjustment
      Off